From Fringe to Pharma: Eli Lilly’s $3.8B AtaiBeckley Acquisition Signals the Mainstreaming of Psychedelic Medicine
The pharmaceutical landscape is undergoing a profound transformation. Once relegated to the periphery of medical research and hindered by decades...
